Hoey Investments »

Allogene Therapeutics shares owned by Hoey Investments

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Hoey Investments from 13F filings

Historical chart of Hoey Investments investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Hoey Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Hoey Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $699 300 2.33
2024-06-30 $699 300 2.33
2024-03-31 $1.3k 300 4.47

More positions owned by Hoey Investments

Nvidia Corporation Call Call Option (Principal) (NVDA)
Amazon Call Call Option (Principal) (AMZN)
Microsoft Corporation (MSFT)
Meta Platforms Call Call Option (Principal) (META)
Apple (AAPL)
Crowdstrike Hldgs Call Call Option (Principal) (CRWD)
Palo Alto Networks (PANW)
Wells Fargo & Company (WFC)
Broadcom (AVGO)
Bank of America Corporation (BAC)
JPMorgan Chase & Co. (JPM)
Uber Technologies (UBER)
Ge Aerospace Com New (GE)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Hoey Investments

Top funds holding Allogene Therapeutics

Tpg Gp A
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Capital World Investors
Lynx1 Capital Management
PRIMECAP Management Company
Citadel Advisors
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Geode Capital Management
Two Sigma Investments
Wildcat Capital Management

View all funds holding Allogene Therapeutics